Earnings season is slowing down as we head into March, and judging by the number of dividend stocks increasing payouts this week, investors can start to take a breather as they wait for the next quarter to begin.
Hot Medical Companies To Invest In Right Now: PetroChina Company Limited(PTR)
PetroChina Company Limited produces and distributes oil and gas in the People?s Republic of China. It operates in four segments: Exploration and Production, Refining and Chemicals, Marketing, and Natural Gas and Pipeline. The Exploration and Production segment explores, develops, produces, and markets crude oil and natural gas, oilsands, and coalbed methane. As of December 31, 2010, it had 11,278 million barrels of proved reserves of crude oil; and 65,503 billion cubic feet of proved reserves of natural gas. The Refining and Chemicals segment engages in the refining of crude oil and petroleum products; and production and marketing of petrochemical products, derivative petrochemical products, and other chemical products. This segment?s product line comprises processed crude oil, gasoline, kerosene, diesel, ethylene, synthetic resins, synthetic fiber materials, polymers, synthetic rubber, and urea. The Marketing segment involves in the marketing of refined products and tradi ng businesses. It operated 17,996 service stations. The Natural Gas and Pipeline segment engages in the transmission of natural gas, crude oil, and refined products; and the sale of natural gas. It had a total length of 56,840 kilometers (km) of oil and gas pipelines, including 32,801 km of natural gas pipelines, 14,782 km of crude oil pipelines, and 9,257 km of refined product pipelines. The company was founded in 1988 and is headquartered in Beijing, the People?s Republic of China. PetroChina Company Limited is a subsidiary of China National Petroleum Corporation.
Advisors' Opinion:- [By Tyler Crowe]
Surprisingly, our energy boom could help China, but not in the way you might think. The energy sector in the U.S. has been an incubator for innovative drilling techniques and technologies over the past few years. Now we have a near monopoly on the technology. Like the U.S., China has massive shale gas deposits, and the technology we possess could help them develop domestic sources and allow them to become more energy self-sufficient. We're starting to see it happen. Royal Dutch Shell (NYSE: RDS-A ) has signed a deal with PetroChina (NYSE: PTR ) to spend $1 billion a year to develop shale resources there. Also, fracking�specialists�Haliburton (NYSE: HAL ) and Schlumberger (NYSE: SLB ) are partnering with various Chinese companies to supply the country with hydraulic fracturing equipment and specialty fluids.�
- [By vaninaegea]
I find the analysis and comparison between companies with base in different geographies an entertaining exercise that offers a singular perspective upon future prospects. In other words, business activities are approached from diverse angles according to social, political, and economical background. Hence, Petroleo Brasileiro (PBR) and PetroChina (PTR) do compete in the same segments, but results are separated by a gamut of particularities.
- [By GuruFocus]
In the past you have made a few investments in China, Petrol China (PTR), BYD, given growing importance, what advice would you give to Chinese leadership?
Top 5 Dividend Companies To Watch In Right Now: Becton Dickinson and Company(BDX)
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company?s BD Medical segment produces medical devices that are used in various healthcare settings. This segment?s products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes, pen needles, and other drugs to treat diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Diagnostics segment provides products for the safe collection and transport of diagnostics specimens, as well as instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment?s products consist of integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; and plated media. The company?s BD Biosciences segment produces research and clinical tools that facilitate the study of cells and their components. This segment?s products comprise fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. It markets its products through independent distribution channels and independent sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Advisors' Opinion:- [By Peter Stephens]
The competition
In terms of competition, medical devices and diagnostics accounted for 21% of�Abbott Labs'� (NYSE: ABT ) �total sales in 2013, with�Becton, Dickinson� (NYSE: BDX ) �also focusing on this area. Abbott experienced a strong year in this space and delivered total sales growth of 5.9%, even when a negative currency impact of 2.4% is taken into account. A 10.8% increase in volume drove the growth, while competitive pricing had a negative impact on total sales. However, reduced prices did not translate into falling margins, as Abbott drove through significant efficiencies so as to increase operating margin from 19.2% in 2011 to 22.2% in 2013, with a more focused and leaner supply chain making a big difference. - [By ovenerio]
Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC). In this article, let麓s concentrate in one particular hedge fund and try to see the principal holdings in its portfolio. I will look into America First Investment Advisor.Recently the fund reported its equity portfolio, as at the end of June. The total value of the portfolio amounted to $222.9 million, up from $203.2 million disclosed at the end of the previous quarter. Consequently, the fund's total return was 9.7% in the last quarter. The filing revealed that at the end of June, the fund added 14 new positions to its equity portfolio, and sold out of 24 other companies. The top ten portfolio holdings as of the end of the quarter represented 41.8%. The largest changes from previous 13-F麓s fillings are in the tech and energy sectors.In this article, we have selected three companies, in which the fund holds the largest stakes, in terms of market value.The first on the list is The Clorox Company (CLX), in which the fund disclosed a $10.53 million stake with over 115,150 shares. The company is a diversified producer of household cleaning, grocery and specialty food products is also a leading producer of natural personal care products.Long-Term VisionIn October 2013, Clorox introduced its 2020 Strategy. The 2020 Strategy focuses on delivering long-term, profitable growth through the year 2020. The key elements of its strategy to grow sales and earnings over the long term are: category, channel and geographic expansion, increased brand investment, and cost reductions.The company's long-term financial goals include:Growing net sales 3-5 percent annuallyExpanding EBIT margin 25-50 basis points annuallyGenerating free cash flow of 10% to 12% of sales annuallyIt has improved earnings
- [By Ben Levisohn]
Becton Dickinson (BDX) has gained 1.2% to $101.97 this morning after�Piper Jaffray�raised the stock to Overweight from Neutral. Analysts�William Quirk and�David Clair�explain why they’re optimistic about the medical technology company:
Associated PressObservations from multiple diagnostic conferences all suggest significant interest in�microbiology investment. This interest spans track systems (Kiestra), new identification�technologies (Maldi/BioTyper) and Molecular (gram +/- assays). When considering�AST (antimicrobial susceptibility testing) recall from Siemens, we believe BD’s�microbiology business is poised to accelerate its performance over the next several years.�Combined with a delayed JNJ/Ypsomed pen needle launch and incremental European�safety adoption, we believe numbers for BD will continue to climb…
They also raised their price target to $117 from $91.
While Becton has gained today,�Johnson & Johnson�(JNJ) has dropped 0.6% to $88.50,�Medtronic�(MDT) has fallen 1%to $53.43,�Boston Scientific�(BSX) has declined 0.9% to $11.79 and Edwards Lifesciences (EW) is off 1.2% at $70.90.
Top 5 Dividend Companies To Watch In Right Now: ConocoPhillips(COP)
ConocoPhillips operates as an integrated energy company worldwide. The company?s Exploration and Production (E&P) segment explores for, produces, transports, and markets crude oil, bitumen, natural gas, liquefied natural gas, and natural gas liquids. Its Midstream segment gathers, processes, and markets natural gas; and fractionates and markets natural gas liquids in the United States and Trinidad. The company?s Refining and Marketing (R&M) segment purchases, refines, markets, and transports crude oil and petroleum products, such as gasolines, distillates, and aviation fuels. Its Chemicals segment manufactures and markets petrochemicals and plastics. This segment offers olefins and polyolefins, including ethylene, propylene, and other olefin products; aromatics products, such as benzene, styrene, paraxylene, and cyclohexane, as well as polystyrene and styrene-butadiene copolymers; and various specialty chemical products comprising organosulfur chemicals, solvents, catalyst s, drilling chemicals, mining chemicals, and engineering plastics and compounds. The company?s Emerging Businesses segment develops new technologies and businesses. It focuses on power generation; and technologies related to conventional and nonconventional hydrocarbon recovery, refining, alternative energy, biofuels, and the environment. This segment also offers E-Gas, a gasification technology producing high-value synthetic gas. ConocoPhillips was founded in 1917 and is based in Houston, Texas.
Advisors' Opinion:- [By Arjun Sreekumar]
Similarly, ConocoPhillips (NYSE: COP ) recently said it is suspending plans to drill in Alaskan waters in 2014 because of regulatory, permitting, and other uncertainties, while Statoil (NYSE: STO ) announced last year that it will postpone drilling in the American Arctic until 2015. To be sure, these companies have good reasons to be hesitant in their Arctic ambitions.
- [By Matt DiLallo]
Finally, last year was the best ever for deepwater discoveries, as�producers�smashed the previous record by 40%. However, those discoveries never would have happened if crude oil prices hadn't been hovering around $100 a barrel the past three years. Higher oil prices are encouraging companies�to invest in exploration of the deepwater in the Gulf of Mexico, a move that's just starting to pay off. ConocoPhillips (NYSE: COP ) , for one, has already announced two major discoveries in the Gulf this year, discoveries that might not have happened if the price of oil was lower.
- [By Jonathan Yates]
There has been a great deal of concern about the United States suffering from a "lost generation" as Japan has now for several. For investors in oil, this has certainly not been the case: A recent article in The Wall Street Journal noted that oil has risen 310% (Brent Crude) over the last decade. The future looks equally promising for investments in the sector such as ConocoPhillips (NYSE: COP), Suncor Energy (NYSE: SU), Americas Petrogas (BOE.V), and Octagon 88 (OTCBB: OCTX).
Top 5 Dividend Companies To Watch In Right Now: Telefonica SA(TEF)
Telefonica, S.A. provides fixed and mobile telephony services primarily in Spain, rest of Europe, and Latin America. Its fixed telecommunication services include PSTN lines; ISDN accesses; public telephone; local, domestic, and international long distance and fixed-to-mobile communications; corporate communications; video telephony; supplementary and business-oriented value-added services; network services; leasing and sale of handset equipment; and telephony information services. The company?s Internet and broadband multimedia services comprise Internet service provider service; portal and network services; retail and wholesale broadband access; narrowband switched access to Internet; naked ADSL, a broadband connection; residential-oriented value-added services; companies-oriented value-added services; television services, such as IPTV, cable television, and satellite television; and Fiber to the Home, a service for high speed Internet access and digital video recording. Its data and business-solutions services principally include leased lines; virtual private network services; fiber optics services; the provision of hosting and application; outsourcing and consultancy services; desktop services; and system integration and professional services. The company?s wholesale services for telecommunication operators primarily comprise domestic interconnection services; international wholesale services; leased lines for other operators? network deployment; local loop leasing under the unbundled local loop regulation framework; and bit stream services. It also offers various mobile and related services and products that include mobile voice services, value added services, mobile data and Internet services, wholesale services, corporate services, roaming, fixed wireless, and trunking and paging services. The company has a strategic alliance with China Unicom (Hong Kong) Limited. Telefonica, S.A. was founded in 1924 and is headquartered in Madrid, Spai n.
Advisors' Opinion:- [By Holly LaFon]
Charlie: Yes, I have a question. Do you think the opportunity is more in stocks or in debt, or both? If you look at Spain, the biggest companies in Spain, one is a bank, Bank Santander (STD). The other is Telefonica (TEF), a phone company. What other opportunities do you see there?
- [By Dan Caplinger]
Is Europe back?
Certainly, some of the enthusiasm about Europe has to do with the stabilization of economic prospects throughout the region. Germany, France, and Spain are still reporting sluggish GDP numbers, but some early signs suggest that the recession could already have hit bottom in many countries in Europe. Perhaps more importantly, just the fact that conditions on the continent haven't gotten markedly worse has seemed to bolster investor confidence. In particular, Spain's recovery has given investors in Telefonica (NYSE: TEF ) new hope that efforts to keep its telecom business strong not just in Europe but in Latin America as well could bear fruit.
No comments:
Post a Comment